At the Payer Exchange Summit V, sponsored by the Community Oncology Alliance, held October 24-25, 2016, in Tyson’s Corner, Virginia, Bruce Gould, MD, presented an overview of how cancer care has improved over the years, what the challenges are, and how practices can adapt to payment reform.
At the Payer Exchange Summit V, sponsored by the Community Oncology Alliance (COA), held October 24-25, 2016, in Tyson’s Corner, Virginia, Bruce Gould, MD, medical director, Northwest Georgia Oncology Center, presented an overview of how cancer care has improved over the years, what the challenges are, and how practices can adapt to payment reform.
“The number of new cancer cases and survivors are expected to rise,” Gould said. “Survivors will increase from 11.7 million in 2007 to 18 million in 2020. Patients are living longer, especially with multiple treatment options available—however, the new treatments are expensive.” Melanoma, for example, has seen a significant improvement in patient survival, especially after the checkpoint inhibitors arrived on the scene. “But these drugs come with a significant price tag,” Gould said.
Gould went on to share the findings of a Milliman report, commissioned by COA, that did a cost of care analysis to identify drivers of cancer care costs. “Hospitals—academic ones in particular, were identified as major cost drivers,” he said. “There’s a significant consolidation of practices with hospitals, and cost of care is definitely much higher in hospitals than in private practice.”
What is COA doing about this? Gould described the Oncology Medical Home (OMH) model, which was initiated by COA, as well as the associated accreditation program.
“We have been speaking about the OMH concepts across the country with various practices, and several institutions have been adopting this care model,” Gould said. OMH assures practices better value for the dollars spent, provide patients care at home, and is a path to cost savings, he added.
The OMH accreditation program helps validation of compliance standards, appropriate structures and processes, and the need to have an EHR, Gould told the audience. “Further, there are 5 domains of care that are the primary focus of the program, namely: patient engagement, expanded access, comprehensive team-based care, evidence-based medicine, and quality improvement projects,” Gould said. He then highlighted some of the nuances of the various domains:
“COA has multiple projects and has commissioned several studies to address these issues,” Gould said.
ASCO GU Posters Address Cost-Effectiveness, Implementation Barriers for New mUC Treatments
February 13th 2025Health systems are facing hurdles to implementing new and effective metastatic urothelial carcinoma (mUC) therapies into practice due to high costs and a lack of targeted initiatives to aid health care providers with integration.
Read More
Evolent’s Wonsettler Sees Outcomes-Based Reimbursement as “A Healthy Tool”
February 7th 2025Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from the 2021 FDA approval of aducanumab (Aduhelm) and use of the accelerated approval pathway.
Read More